123

UNITE glioblastoma

Understanding and targeting resistance in glioblastoma

We aim to develop concepts to predict and monitor treatment response and failure, and ultimately, to discover novel therapies for glioblastoma patients

More about UNITE
Link to: Research
UNITE Reasearch Header Image

RESEARCH AND WORK PACKAGES

TELL ME MORE
Brain Tumor scaled

UNITE School of Neurooncology

LEARN MORE
Member Teaser Image

MEMBERS

UNITE Glioblastoma brings together physician-scientists and scientists from Heidelberg University Hospital, University Hospital Mannheim, the German Cancer Research Center and Mannheim University of Applied Sciences.

GET TO KNOW ALL MEMBERS

EVENTS

UNITE coordinates regular seminars and symposia with internal and external speakers presenting the latest research findings in glioblastoma research.

FIND OUT ABOUT CURRENT UNITE EVENTS
Event Teaser Image

Participating Institutions

More about

NEWS

All News
Header Image 3UNITE

Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors

Research findings related to UNITE work packages B04/C05/C06N Personalized drug screening aims to improve the survival of glioblastoma (GBM) patients by identifying effective patient-individual…
Read more
header ueber uniteUNITE

ERC Starting Grant Awarded for Pioneering Brain Tumor Research

We are delighted to announce that Varun Venkataramani (A07) has received an ERC Starting Grant from the European Research Council. Over the next five years, his project BITE (Brain Tumor Progression via…
Read more
header ueber uniteUNITE

IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial

Research findings related to UNITE work packages A03/A06/B01/B03/B06N/C02/C06N The clonal glioma driver mutation IDH1R132H gives rise to a major histocompatibility class II-restricted neoepitope.…
Read more